Filter
1429
Text search:
pharmaceutical
products
Featured
Recommendations
133
New Publications
384
Language
Document type
No document type
671
Studies & Reports
297
Guidelines
235
Manuals
84
Strategic & Response Plan
69
Fact sheets
30
Training Material
23
Situation Updates
10
Resource Platforms
6
Brochures
2
Infographics
1
Online Courses
1
Countries / Regions
Kenya
65
Global
57
Ethiopia
46
India
46
Nigeria
32
South Africa
30
Western and Central Europe
30
Sierra Leone
27
Uganda
26
Ghana
25
Liberia
24
Rwanda
24
Tanzania
22
Namibia
21
Ukraine
19
Zambia
18
Malawi
17
Africa
17
Philippines
15
Nepal
15
Zimbabwe
14
Bangladesh
14
Indonesia
13
Latin America and the Carribbean
13
Eastern Europe
13
Myanmar / Burma
11
Eswatini/ Swaziland
9
Lesotho
9
West and Central Africa
8
Syria
7
Botswana
7
Burkina Faso
6
Cambodia
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Asia
6
Senegal
5
Congo, Democratic Republic of
5
East and Southern Africa
5
Cameroon
4
Haiti
4
Thailand
4
Benin
4
Venezuela
4
Guinea
3
South Sudan
3
Jordan
3
China
3
Mozambique
3
Sudan
3
North Macedonia
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
Germany
2
Egypt
2
Papua New Guinea
2
Central African Republic
2
Brazil
2
Serbia
2
Madagascar
2
Middle East and North Africa
2
Western Pacific Region
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
United Kingdom
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Malaysia
1
Peru
1
Ecuador
1
Libya
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
580
Clinical Guidelines
101
Key Resources
68
Public Health
65
Women & Child Health
40
Pharmacy & Technologies
37
Capacity Building
10
Annual Report MEDBOX
1
Toolboxes
Pharmacy
178
AMR
163
COVID-19
90
HIV
64
TB
64
Mental Health
56
Planetary Health
39
NTDs
36
Rapid Response
28
Global Health Education
27
NCDs
26
Caregiver
25
Conflict
24
Malaria
23
Health Financing Toolbox
21
Ebola & Marburg
20
2.0 Rapid Response
15
Disability
9
Refugee
7
Specific Hazards
7
Polio
6
Natural Hazards
6
Zika
3
Cholera
1
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List
...
This document proposes surveillance objectives and describes global standards for a minimal basic respiratory disease surveillance system for the monitoring of influenza. The agreement on objectives allows for the prioritization of the many facets of influenza that might be measured and tracked. Use
...
Call to action by the Global Leaders Group on Antimicrobial Resistance on reducing antimicrobial discharges from food systems, manufacturing facilities and human health systems into the environment.
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci
...
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin
...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen
...
Version 1.1
Department of Mental Health and Substance Abuse
Zambia National Formulary 04
recommended
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Health Systems in Transition. Vol. 5 No.3 2015
A Handbook for country programmes
